Increasing demand for personalized medicines and supplements is broadening the market for dosage forms that are quick, convenient and safe for people to use. As a result, many product developers are turning to contract development and manufacturing organizations (CDMOs) with highly specialized formulation and process technology competencies.
In this special feature, published in Drug Development & Delivery in June 2019 (Vol 19 No 5), HERMES PHARMA’s Dr. Detlev Haack (Head of R&D), discusses amongst others:
- Why modern consumers expect convenience from their personalized medicines and supplements
- How innovative dosage forms, such as HERMES NutriCaps, are helping to meet consumer expectations around ease-of-use
- Why CDMOs with specialist formulation expertise are ideally placed to develop new, optimized dosage forms for existing therapeutics and supplements
- How robust risk analysis can support the efficient development and regulatory approval of new formulations